Gwen Lapham to Substance-Related Disorders
This is a "connection" page, showing publications Gwen Lapham has written about Substance-Related Disorders.
Connection Strength
0.828
-
Validity of the Single-Item Screen-Cannabis (SIS-C) for Cannabis Use Disorder Screening in Routine Care. JAMA Netw Open. 2022 11 01; 5(11):e2239772.
Score: 0.146
-
Cannabis use, other drug use, and risk of subsequent acute care in primary care patients. Drug Alcohol Depend. 2020 11 01; 216:108227.
Score: 0.125
-
Screening for Drug Use in Primary Care: Practical Implications of the New USPSTF Recommendation. JAMA Intern Med. 2020 08 01; 180(8):1050-1051.
Score: 0.125
-
Routine Assessment of Symptoms of Substance Use Disorders in Primary Care: Prevalence and Severity of Reported Symptoms. J Gen Intern Med. 2020 04; 35(4):1111-1119.
Score: 0.121
-
Identifying Problematic Substance Use in a National Sample of Adolescents Using Frequency Questions. J Am Board Fam Med. 2019 Jul-Aug; 32(4):550-558.
Score: 0.116
-
Integration of screening, assessment, and treatment for cannabis and other drug use disorders in primary care: An evaluation in three pilot sites. Drug Alcohol Depend. 2019 08 01; 201:134-141.
Score: 0.116
-
Prevalence of clinically recognized alcohol and other substance use disorders among VA outpatients with unhealthy alcohol use identified by routine alcohol screening. Drug Alcohol Depend. 2014 Feb 01; 135:95-103.
Score: 0.079